Liu JR, Chen BQ, Yang BF, Dong HW, Sun CH, Wang Q, Song G, Song YQ. Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol 2004; 10(3): 348-351
Corresponding Author of This Article
Dr. Bao -Feng Yang, Department of Pharmacology, Harbin Medical University, Harbin 150086, Heilongjiang Province, China. email@example.com Telephone: +86-451-53641309 Fax: +86-451-53648617
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jia-Ren Liu, Bing-Qing Chen, Hong-Wei Dong, Chang-Hao Sun, Qi Wang, Public Health College, Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Bao-Feng Yang, Guo Song, Department of Pharmacology, Harbin Medical University, Harbin 150086, Heilongjiang Province, China You-Qiang Song, Department of Biochemistry and The Genome Research Center, The University of Hong Kong, Hong Kong, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Supported by The National Natural Science Foundation of China, No. 30200229 and The Postdoctoral Foundations of China and Heilongjiang Province, China
Correspondence to: Dr. Bao -Feng Yang, Department of Pharmacology, Harbin Medical University, Harbin 150086, Heilongjiang Province, China. firstname.lastname@example.org Telephone: +86-451-53641309 Fax: +86-451-53648617
Received: August 26, 2003 Revised: October 5, 2003 Accepted: October 12, 2003 Published online: February 1, 2004
AIM: To investigate the effect of β-ionone on the growth and apoptosis of gastric adenocarcinoma cell line SGC-7901.
METHODS: Using MTT, fluorescence dye (Hoechst-33258), transmission electron microscopy and the TUNEL assay, we examined growth and apoptosis of SGC-7901 cells treated with β-ionone at various concentrations (i.e. 25, 50, 100 and 200 μmol/L) for 24 h, 48 h.
RESULTS: The growth of SGC-7901 cells was inhibited by β-ionone. Seven days after treatment with β-ionone at four concentrations, the inhibition rates were 12.04%, 30.59%, 78.25% and 94.15%, respectively. The IC50 value of β-ionone for SGC-7901 cells was estimated to be 89 μmol/L. The apoptotic morphology was demonstrated in SGC-7901 cells treated with β-ionone by Hoechst-33258 staining and electron microscopy. Apoptosis was also shown in β-ionone-treated SGC-7901 cells by the TUNEL assay.
CONCLUSION: β-ionone can inhibit cell proliferation and induce apoptosis of SGC-7901 cells. However, the mechanism needs to be further investigated.
Key Words: $[Keywords]
Citation: Liu JR, Chen BQ, Yang BF, Dong HW, Sun CH, Wang Q, Song G, Song YQ. Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World J Gastroenterol 2004; 10(3): 348-351
Following the dietary guidelines[1,2] that emphasize the importance of fruits, vegetables and grains could lead to an estimated 35% reduction in cancer deaths, fruits, vegetables and grains are potential sources of anticarcinogenic agents[4-11], such as nondigestible carbohydrates and micronutrients including β-ionone, ascorbic acid, γ-tocopherol, isoprenoids and folic acid. Epidemiological evidence suggested that intake of these constituents could lead to a reduced risk of chronic diseases such as cancer and cardiovascular disorders[3,12-14]. β-ionone, enriched in many fruits, vegetables and grains, is a common intermediate product of up to 22000 isoprenoids and could exert potent anticarcinogenic and antitumor activities at the pharmacological level[16,17]. It has been documented that β-ionone could suppress the proliferation of melanoma, breast cancer and meningioma cells[18-21]. β-ionone has also been shown to have an effect on apoptosis of vascular endothelial cells and tumor cells[23,24]. Although its exact mechanisms are not clear, the inhibitory effect of β-ionone on the proliferation of rapidly dividing cells has been demonstrated. In many instances, growth inhibition following terminal differentiation or anticancer drug treatment results in apoptosis.
Gastric cancer is one of the most frequent neoplasms in China and some other parts of the world[25-33]. Chemoprevention is always used as the main treatment for advanced cancer, and has been under intense investigation[34-49]. Understanding the mechanisms through which β-ionone suppresses the proliferation of gastric adenocarcinoma cells could provide a way to prevent this disease in general population. Therefore, in this study, we explored whether and how β-ionone induced apoptosis of human gastric adenocarcinoma cells.
MATERIALS AND METHODS
β-ionone, 4-(2, 6, 6-trimethyl-1-cyclohexenyl)-3-buten-2-one with > 95 % purity, was purchased from Sigma (USA). It was dissolved in absolute ethanol and diluted to the following concentrations: 25, 50, 100 and 200 μmol/L.
Human gastric adenocarcinoma cell line, SGC-7901 (Cancer Research Institute of Beijing, China), was cultured in RPMI 1640 medium (pH7.2 - pH7.4), supplemented with fetal calf serum 10%, penicillin (100 U/ml) and streptomycin (100 μg/ml) at 37 °C with a humidified atmosphere of 5% CO2. The cells were sub-cultured with a mixture of ethylenedinitrile tetraacetic acid (EDTA) and trypsin (Sigma).
MTT assay for determination of cell growth
SGC-7901 cells were seeded in eight 96-well plates, each well containing 3.0 × 103 cells. After 24 h, different concentrations of β-ionone were added with. On the next day, 0.05 mL of 1.0 mg/ml 3-(4,5-dimethylthiazole-2-yl)-2,5-dipenyltetrazolium bromide (MTT, Sigma) was added to one of the eight plates. After 4 h, culture media were discarded followed by addition of 0.2 ml dimethyl sulfoxide (DMSO) and vibration for 2 min. The absorbance was measured at 570 nm using a model 550 microplate Reader. β-ionone concentration required to inhibit the net increase in the 48 h cell count by 50% (IC50) was calculated based on the plots of data from three or more evaluations. The means were obtained on each of seven days and used to draw a curve of cell proliferation. The inhibitory rates (IR) on the 7th day were calculated as follows:
Hoechst-33258 staining for determination of morphological changes of apoptotic cells
Morphological changes of apoptotic cells were determined by fluorescence microscopy. Briefly, the cells were collected and fixed in 100% ethanol, stained with 0.5 mmol/L Hoechst-33258 (Sigma) for 3 min at 37 °C, then visualized under a fluorescence microscope with ultraviolet (UV) excitation at 300-500 nm. The cells with nuclei containing condensed chromatin or cells with fragmented nuclei were defined as apoptotic cells.
Observation of apoptotic cells with transmission electron microscopy
The cultured SGC-7901 cells treated with β-ionone at different concentrations were scraped off and harvested. Subsequently, the cells were immersed with Epon 821, embedded in capsules and converged at 60 °C for 72 h, and then ultrathin sections (60 nm) were prepared and stained with uranyl acetate and lead citrate. The ultrastructure of cells was examined by transmission electron microscopy.
TUNEL assay for determination of apoptosis cells
The TUNEL reaction could preferentially label DNA strand breaks generated during apoptosis, and allow discrimination of apoptosis from necrosis and primary DNA strand breaks induced by cancer chemoprevention agents. SGC-7901 cells were treated for 24 h and 48 h with β-ionone at various concentrations and collected by centrifugation. Specimens were fixed immediately in 4% formaldehydum polymerisatum and embedded in paraffin. Apoptosis of SGC-7901 cells was evaluated by using an in situ cell death detection kit (Roche Co. Ltd, Germany). The sections were deparaffinized in xylene and rehydrated through graded alcohol, treated with proteinase K and then 0.3% H2O2, labeled with fluorescein dUTP in a humidified box for 1 h at 37 °C. The cells were then combined with POD-horseradish peroxidase, colorized with diaminobenzidine tetrahydrochloride (DAB). Controls consisted of omission of fluorescein dUTP. Cells were visualized under a light microscope. The apoptotic index (AI) was calculated as follows: AI = (number of apoptotic cells/total number counted) × 100%.
Data were expressed as mean ± 22000 SD. Analysis of data was performed using the Student’s t test or one-way ANOVA. P < 0.05 was considered as statistically significant.
Inhibition of SGC-7901 cell proliferation by β-ionone
SGC-7901 cells were treated with β-ionone at various concentrations for 1-7 days, and the cell viability was determined as described above by MTT assay. As shown in Figure 1, β-ionone inhibited the growth of gastric adenocarcinoma cells in a dose- and time-dependent manner. The growth of the cells treated with β-ionone at concentrations of 100 and 200 μmol/L was significantly slower than that of the negative control within 7 days (P < 0.05). SGC-7901 cells incubated with 25 and 50 μmol/L of β-ionone grew slower, albeit not significantly than the negative control. β-ionone at 100 μmol/L and 200 μmol/L had an inhibitory effect of more than 90% on tumor cell growth 3 days after treatment. The inhibitory rate at the four progressively increasing concentrations of β-ionone was 12.04%, 30.59%, 78.25% and 94.15% 7 days after treatment. The IC50 value for β-ionone was estimated to be 89 μmol/L.
Figure 1 Proliferation kinetics of SGC-7901 cells treated with β-ionone at various concentrations.
Morphological changes of apoptotic SGC-7901 cells treated with β-ionone
SGC-7901 cells in the negative control group exhibited a round shape, clear edge and homogeneous staining (Figure 2A). However, after 24 h and 48 h exposure to β-ionone, SGC-7901 cells began to show morphologic features of apoptosis, such as cell shrinkage, chromatin condensation and nuclear pyknosis (Figure 2B). The ultrastructural changes were observed by electron microscopy showing early changes of apoptosis including nuclear chromatin condensation and cell shrinkage (Figures 3A & 3B).
Figure 2 β-ionone-induced apoptosis in SGC-7901 cells stained with Hoechst-33258 (× 400).
A: control SGC-7901 cells, B: ex-perimental cells treated with β-ionone showing nuclear shrink-age or fragmentation.
Figure 3 Ultrastructural changes of SGC-7901 cells treated with 100 μmol/L β-ionone for 24 h (× 15000).
A: SGC-7901 cells in the control group, B: experimental SGC-7901 cells treated with β-ionone showing early changes of apoptosis in which nuclear chromatin condensation and cell shrinkage were observed.
Apoptosis detected by TUNEL assay in SGC-7901 cells treated with β-ionone
The cells with positive staining in the nuclei were defined as apoptotic cells (Figure 4). The results showed that after treatment of SGC-7901 cells with β-ionone at different concentrations for 24 h and 48 h, the AIs were significantly increased in a dose- and time-dependent manner (Table 1).
Table 1 Apoptotic index (AI) of SGC-7901 cells treated by β-ionone.
0.15 ± 0.087
0.12 ± 0.03
0.87 ± 0.23b
0.47 ± 0.15
3.43 ± 1.00b
1.67 ± 0.53b,c
8.50 ± 19.2b,c
4.78 ± 1.32b,c,d
11.85 ± 3.83b,c,d
a: X experiments were performed and Y cells were counted in each experiment, b: P < 0.05, comparison between 24 h and 48 h, c: P < 0.05 compared with negative control, d: P < 0.05 as deter-mined by one-way ANOVA.
Figure 4 Apoptotic cells induced by β-ionone (200 μmol/L 48 h) in SGC-7901 cells detected TUNEL assay (× 400).
Epidemiologic studies have revealed a strong inverse association between frequency of intake of plant-derived foods and cancer incidence. β-ionone, widely distributed in fruits and vegetables, has been found to be a common intermediate product of up to 22000 isoprenoids and many other phytochemicals. It could exert broad and potent anticarcinogenic and antitumor activities when fed at pharmacological levels. β-ionone could also suppress the proliferation of melanoma and breast cancer cells[16-18]. However, the effects of β-ionone on gastric adenocarcinoma cells have not been reported.
Isoprenoid-mediated suppression of cell growth is clearly independent of a mutated ras function. β-ionone could suppress the proliferation of B16 and HL-60 cells that express ki-ras and n-ras, respectively. The study from Mo et al showed that β-ionone also suppressed the proliferation of Caco-2 and MCF-7 cells which express wild-type ras. The action, like that of lovastatin, is independent of ras function. Both β-ionone and lovastatin can arrest HL-60 promyelocytic leukemia cells in the G1 phase of the cell cycle in a concentration-dependent manner. The present study demonstrated that β-ionone inhibited the growth of human gastric adenocarcinoma SGC-7901 cells in a dose- and time-dependent manner. The inhibition rates were 12.04%, 30.59%, 78.25% and 94.15% 7 days after treatment with β-ionone at 25, 50, 100 and 200 mmol/L, respectively. The IC50 value for β-ionone was estimated to be 89 μmol/L.
Apoptosis, also known as programmed cell death, is a natural process of cell suicide which plays a critical role in the development and homeostasis of metazoans[50,51]. It is a complex process regulated by a variety of factors such as Bcl-2, Fas and p53. The isoprenoid-mediated initiation of apoptosis might be independent of a mutated p53 function. β-ionone could initiate apoptosis in B16 and MCF-7 cells which express wild type p53 and in Caco-2 cells which express mutated p53 as well as in p53-null HL-60 cells. However, whether β-ionone has any effect on the other apoptotic pathways in cancer cells is not understood.
In conclusion, β-ionone can inhibit cell growth and proliferation and induce apoptosis of SGC-7901 cells. However, the mechanism by which β-ionone blocks cell proliferation and induces apoptosis of SGC-7901 cells needs to be further investigated.
We thank Dr. Dong-Yan Jin for critically reading and revising the manuscript.
Edited by Xia HHX and Wang XL
Shikany JM, White GL. Dietary guidelines for chronic disease prevention.South Med J. 2000;93:1138-1151.
Kant AK, Schatzkin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women.JAMA. 2000;283:2109-2115.
Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence.Nutr Cancer. 1992;18:1-29.
Jaga K, Duvvi H. Risk reduction for DDT toxicity and carcinogenesis through dietary modification.J R Soc Promot Health. 2001;121:107-113.
Witte JS, Longnecker MP, Bird CL, Lee ER, Frankl HD, Haile RW. Relation of vegetable, fruit, and grain consumption to colorectal adenomatous polyps.Am J Epidemiol. 1996;144:1015-1025.
Elson CE. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease.J Nutr. 1995;125:1666S-1672S.
Elson CE, Yu SG. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables.J Nutr. 1994;124:607-614.
Huang C, Huang Y, Li J, Hu W, Aziz R, Tang MS, Sun N, Cassady J, Stoner GD. Inhibition of benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor kappaB by black raspberry extracts.Cancer Res. 2002;62:6857-6863.
Serafini M, Bellocco R, Wolk A, Ekström AM. Total antioxidant potential of fruit and vegetables and risk of gastric cancer.Gastroenterology. 2002;123:985-991.
Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study.Eur J Cancer Prev. 2002;11:365-368.
Devasena T, Menon VP. Enhancement of circulatory antioxidants by fenugreek during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.J Biochem Mol Biol Biophys. 2002;6:289-292.
Michaud DS, Pietinen P, Taylor PR, Virtanen M, Virtamo J, Albanes D. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study.Br J Cancer. 2002;87:960-965.
Ito LS, Inoue M, Tajima K, Yamamura Y, Kodera Y, Hirose K, Takezaki T, Hamajima N, Kuroishi T, Tominaga S. Dietary factors and the risk of gastric cancer among Japanese women: a comparison between the differentiated and non-differentiated subtypes.Ann Epidemiol. 2003;13:24-31.
Willett WC. Balancing life-style and genomics research for disease prevention.Science. 2002;296:695-698.
Bach TJ. Some new aspects of isoprenoid biosynthesis in plants--a review.Lipids. 1995;30:191-202.
Mo H, Elson CE. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids.J Nutr. 1999;129:804-813.
Yu SG, Anderson PJ, Elson CE. Efficacy of β-ionone in the chemoprevention of rat mammary carcinogenesis.J Agric Food Chem. 1995;43:2144-2147.
He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo.J Nutr. 1997;127:668-674.
Riebeling C, Forsea AM, Raisova M, Orfanos CE, Geilen CC. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.Br J Cancer. 2002;87:366-371.
Tatman D, Mo H. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells.Cancer Lett. 2002;175:129-139.
Johnson MD, Woodard A, Okediji EJ, Toms SA, Allen GS. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase.J Neurooncol. 2002;56:133-142.
Newton CJ, Xie YX, Burgoyne CH, Adams I, Atkin SL, Abidia A, McCollum PT. Fluvastatin induces apoptosis of vascular endothelial cells: blockade by glucocorticoids.Cardiovasc Surg. 2003;11:52-60.
Elson CE, Peffley DM, Hentosh P, Mo H. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer.Proc Soc Exp Biol Med. 1999;221:294-311.
Burke YD, Ayoubi AS, Werner SR, McFarland BC, Heilman DK, Ruggeri BA, Crowell PL. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention.Anticancer Res. 2002;22:3127-3134.
Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of p16 gene in gastric cancer.World J Gastroenterol. 2003;9:423-426.
Guo HQ, Guan P, Shi HL, Zhang X, Zhou BS, Yuan Y. Prospective cohort study of comprehensive prevention to gastric cancer.World J Gastroenterol. 2003;9:432-436.
Tovey FI, Hobsley M. Post-gastrectomy patients need to be followed up for 20-30 years.World J Gastroenterol. 2000;6:45-48.
Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.World J Gastroenterol. 2001;7:248-253.
Niu WX, Qin XY, Liu H, Wang CP. Clinicopathological analysis of patients with gastric cancer in 1200 cases.World J Gastroenterol. 2001;7:281-284.
Xin Y, Li XL, Wang YP, Zhang SM, Zheng HC, Wu DY, Zhang YC. Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas.World J Gastroenterol. 2001;7:53-59.
Yao YL, Xu B, Song YG, Zhang WD. Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis.World J Gastroenterol. 2002;8:60-63.
Deng DJ. progress of gastric cancer etiology: N-nitrosamides 1999s.World J Gastroenterol. 2000;6:613-618.
Cao WX, Ou JM, Fei XF, Zhu ZG, Yin HR, Yan M, Lin YZ. Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro.World J Gastroenterol. 2002;8:230-232.
Oliveira CP, Kassab P, Lopasso FP, Souza HP, Janiszewski M, Laurindo FR, Iriya K, Laudanna AA. Protective effect of ascorbic acid in experimental gastric cancer: reduction of oxidative stress.World J Gastroenterol. 2003;9:446-448.
Chen C, Liu FK, Qi XP, Li JS. The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs.World J Gastroenterol. 2003;9:242-245.
Zhou HB, Zhu JR. Paclitaxel induces apoptosis in human gastric carcinoma cells.World J Gastroenterol. 2003;9:442-445.
Wu YL, Sun B, Zhang XJ, Wang SN, He HY, Qiao MM, Zhong J, Xu JY. Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.World J Gastroenterol. 2001;7:796-800.
Liu S, Wu Q, Chen ZM, Su WJ. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.World J Gastroenterol. 2001;7:662-666.
Wang X, Lan M, Shi YQ, Lu J, Zhong YX, Wu HP, Zai HH, Ding J, Wu KC, Pan BR. Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell.World J Gastroenterol. 2002;8:54-59.
Wang X, Liu FK, Li X, Li JS, Xu GX. Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro.World J Gastroenterol. 2002;8:253-257.
Xu CT, Huang LT, Pan BR. Current gene therapy for stomach carcinoma.World J Gastroenterol. 2001;7:752-759.
Chen BQ, Xue YB, Liu JR, Yang YM, Zheng YM, Wang XL, Liu RH. Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo (a) pyrene and chemopreventive mechanisms.World J Gastroenterol. 2003;9:44-49.
Liu JR, Chen BQ, Yang YM, Wang XL, Xue YB, Zheng YM, Liu RH. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid.World J Gastroenterol. 2002;8:999-1004.
Li Y, Lu YY. Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells.World J Gastroenterol. 2002;8:213-216.
Wu K, Li Y, Zhao Y, Shan YJ, Xia W, Yu WP, Zhao L. Roles of Fas signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells.World J Gastroenterol. 2002;8:982-986.
Liu JR, Li BX, Chen BQ, Han XH, Xue YB, Yang YM, Zheng YM, Liu RH. Effect of cis-9, trans-11-conjugated linoleic acid on cell cycle of gastric adenocarcinoma cell line (SGC-7901).World J Gastroenterol. 2002;8:224-229.
Xu AG, Li SG, Liu JH, Gan AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer.World J Gastroenterol. 2001;7:403-406.
Gao F, Yi J, Shi GY, Li H, Shi XG, Tang XM. The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species.World J Gastroenterol. 2002;8:36-39.
Morse MA, Stoner GD. Cancer chemoprevention: principles and prospects.Carcinogenesis. 1993;14:1737-1746.
Green DR, Reed JC. Mitochondria and apoptosis.Science. 1998;281:1309-1312.
Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors.Curr Opin Cell Biol. 1999;11:255-260.
Wang NS, Unkila MT, Reineks EZ, Distelhorst CW. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death.J Biol Chem. 2001;276:44117-44128.
Lüschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression.J Biol Chem. 2000;275:24670-24678.
Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling.J Biol Chem. 2000;275:16202-16212.
David-Pfeuty T, Chakrani F, Ory K, Nouvian-Dooghe Y. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.Cell Growth Differ. 1996;7:1211-1225.